Early reperfusion therapy and some of the drugs that reduce the risk of mortality and heart failure following MI prevent progressive adverse remodelling (e.g. angiotensin‐converting enzyme [ACE] inhibitors, angiotensin receptor blockers [ARB], and beta‐blockers).4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14. Here, ACE is linked to myocardial infarction.